4
Impact 6/10
Insider Transaction
$NONE · Tananbaum Steven A.
Summary
GoldenTree Asset Management LP, a 10% owner of Keenova Therapeutics plc, reported a purchase of 137,000 shares at $90.00 per share, totaling $12,330,000. The transaction was a direct open-market purchase, not executed under a 10b5-1 plan.
Key points
- GoldenTree Asset Management, a 10% owner, purchased 137,000 shares at $90.00 each.
- Total transaction value: $12,330,000.
- Post-transaction ownership: 8,579,827 shares.
- Transaction was not executed under a 10b5-1 trading plan.
- Filing reflects a direct open-market purchase (transaction code P).
Insider transaction
InsiderGOLDENTREE ASSET MANAGEMENT LP (10% Owner)
Actionpurchase
Shares137,000
Price$90.00
Total value$12,330,000.00
Owned after8,579,827
Market impact
Price data unavailable.
Why this matters
A $12.3M discretionary buy by a 10% owner signals strong conviction — no 10b5-1 plan means this was an active decision, not automated.
Sector context
_Not applicable._
Risk factors
_Not applicable._
Get filings like this before the market reacts.
Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.